Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center

Table 2 Intraoperative changes in the thromboelastogram tracing (mean ± SD)

	Zenapax(n = 16)	Thymoglobulin(n = 22)	Campath(n = 39)	P value
Stage-I (baseline)
R I	9.26 ± 3.6	9.09 ± 3.88	7.36 ± 4.35	0.195
K I	2.72 ± 0.91	2.73 ± 0.97	2.21 ± 2.96	0.630
ANG I	71.64 ± 5.46	65.9 ± 14.1	66.1 ± 12.25	0.291
MA I	65.11 ± 11.1	59.53 ± 14.56	66.04 ± 13.72	0.223
Stage-II (organ on the field)
R II	9.12 ± 5.23	7.36 ± 3.17	7.15 ± 3.54	0.327
K II	4.26 ± 1.53	3.99 ± 2.1	3.10 ± 2.12	0.176
ANG II	64.25 ± 8.26	60.82 ± 11.66	55 ± 15.72	0.109
MA II	53.58 ± 10.42	53.71 ± 9.7	54.44 ± 15.16	0.974
Stage-III (reperfusion)
R III	9.3 ± 2.7	7.44 ± 2.53	7.74 ± 3.4	0.356
K III	6.13 ± 2.56	4.77 ± 2.1	3.9 ± 2.54	0.088
ANG III	56.13 ± 9.23	58.6 ± 7.36	49.2 ± 15.57	0.072
MA III	47.56 ± 12.5	50.7 ± 10.67	48.67 ± 16.1	0.855
Closing the abdominal incision (final)
R end	9.26 ± 2.58	8.77 ± 3.39	6.38 ± 2.31	0.011a
K end	6.21 ± 2.83	5.13 ± 2.1	2.79 ± 1.62	< 0.0001a
ANGe nd	56.75 ± 12.8	57.47 ± 7.6	58.1 ± 11.13	0.949
MA end	50.56 ± 8.51	51.32 ± 11.76	55.46 ± 9.23	0.339

^aP < 0.05. R: R-time (min); K: Tangential line in the thromboelastogram tracing (min); ANG: α-angle (degree); MA: Maximum amplitude (millimeter).